BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35835581)

  • 1. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical).
    Ricard F; Barrington S; Korn R; Brueggenwerth G; Trotman J; Cheson B; Salles G; Schwartz L; Goldmacher G; Jarecha R; Narang J; Broussais F; Galette P; Liu M; Bajpai S; Perlman E; Gillis J; Smalberg I; Terve P; Zahlmann G; Schmid A
    J Nucl Med; 2023 Feb; 64(2):239-243. PubMed ID: 35835581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical).
    Ricard F; Cheson B; Barrington S; Trotman J; Schmid A; Brueggenwerth G; Salles G; Schwartz L; Goldmacher G; Jarecha R; Narang J; Broussais F; Galette P; Liu M; Bajpai S; Perlman E; Gillis J; Smalberg I; Terve P; Zahlmann G; Korn R
    J Nucl Med; 2023 Jan; 64(1):102-108. PubMed ID: 35835580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
    Cheson BD; Fisher RI; Barrington SF; Cavalli F; Schwartz LH; Zucca E; Lister TA; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    J Clin Oncol; 2014 Sep; 32(27):3059-68. PubMed ID: 25113753
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Tamayo P; Martín A; Díaz L; Cabrero M; García R; García-Talavera P; Caballero D
    Rev Esp Med Nucl Imagen Mol; 2017; 36(5):312-321. PubMed ID: 28483374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revised staging system for malignant lymphoma based on the Lugano classification.
    Munakata W; Terauchi T; Maruyama D; Nagai H
    Jpn J Clin Oncol; 2019 Oct; 49(10):895-900. PubMed ID: 31504700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update.
    Juweid ME; Mueller M; Alhouri A; A-Risheq MZ; Mottaghy FM
    Cancer; 2021 Oct; 127(20):3727-3741. PubMed ID: 34286864
    [No Abstract]   [Full Text] [Related]  

  • 7. [Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)].
    Sýkorová A; Pytlík R; Móciková H; Belada D; Benešová K; Papajík T; Janíková A; Šálek D; Procházka V; Vokurka S; Campr V; Klener P; Kubáčková K; Trněný M
    Klin Onkol; 2016; 29(4):295-302. PubMed ID: 27534788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.
    McCarten KM; Nadel HR; Shulkin BL; Cho SY
    Pediatr Radiol; 2019 Oct; 49(11):1545-1564. PubMed ID: 31620854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging for Staging and Response Assessment in Lymphoma.
    Johnson SA; Kumar A; Matasar MJ; Schöder H; Rademaker J
    Radiology; 2015 Aug; 276(2):323-38. PubMed ID: 26203705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
    Younes A; Hilden P; Coiffier B; Hagenbeek A; Salles G; Wilson W; Seymour JF; Kelly K; Gribben J; Pfreunschuh M; Morschhauser F; Schoder H; Zelenetz AD; Rademaker J; Advani R; Valente N; Fortpied C; Witzig TE; Sehn LH; Engert A; Fisher RI; Zinzani PL; Federico M; Hutchings M; Bollard C; Trneny M; Elsayed YA; Tobinai K; Abramson JS; Fowler N; Goy A; Smith M; Ansell S; Kuruvilla J; Dreyling M; Thieblemont C; Little RF; Aurer I; Van Oers MHJ; Takeshita K; Gopal A; Rule S; de Vos S; Kloos I; Kaminski MS; Meignan M; Schwartz LH; Leonard JP; Schuster SJ; Seshan VE
    Ann Oncol; 2017 Jul; 28(7):1436-1447. PubMed ID: 28379322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.
    Barrington SF; Mikhaeel NG; Kostakoglu L; Meignan M; Hutchings M; Müeller SP; Schwartz LH; Zucca E; Fisher RI; Trotman J; Hoekstra OS; Hicks RJ; O'Doherty MJ; Hustinx R; Biggi A; Cheson BD
    J Clin Oncol; 2014 Sep; 32(27):3048-58. PubMed ID: 25113771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of clinical staging using the Lugano versus Ann Arbor classifications in Japanese patients with Hodgkin lymphoma.
    Makita S; Maruyama D; Maeshima AM; Taniguchi H; Yuda S; Toyoda K; Yamauchi N; Fukuhara S; Munakata W; Kobayashi Y; Kurihara H; Izutsu K; Tobinai K
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):108-114. PubMed ID: 31802636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma.
    Ömür Ö; Baran Y; Oral A; Ceylan Y
    Diagn Interv Radiol; 2014; 20(2):185-92. PubMed ID: 24412817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
    Cheson BD
    Radiol Clin North Am; 2008 Mar; 46(2):213-23, vii. PubMed ID: 18619377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Update on the use of FDG-PET/CT in malignant lymphoma].
    Terauchi T
    Rinsho Ketsueki; 2016; 57(10):2008-2012. PubMed ID: 27795508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT.
    Yoo KH
    Blood Res; 2022 Apr; 57(S1):75-78. PubMed ID: 35483930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/CT for Staging; Past, Present, and Future.
    El-Galaly TC; Gormsen LC; Hutchings M
    Semin Nucl Med; 2018 Jan; 48(1):4-16. PubMed ID: 29195617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma.
    Zanoni L; Mattana F; Calabrò D; Paccagnella A; Broccoli A; Nanni C; Fanti S
    Eur J Radiol; 2021 Aug; 141():109793. PubMed ID: 34148014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.
    Pelosi E; Pregno P; Penna D; Deandreis D; Chiappella A; Limerutti G; Vitolo U; Mancini M; Bisi G; Gallo E
    Radiol Med; 2008 Jun; 113(4):578-90. PubMed ID: 18414808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging and response assessment in lymphomas: the new Lugano classification.
    Cheson BD
    Chin Clin Oncol; 2015 Mar; 4(1):5. PubMed ID: 25841712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.